On September 28, 2022, the Food and Drug Administration (FDA) issued Clinical Decision Support Software final guidance. The guidance clarifies the agency’s scope of oversight and regulation of clinical decision support software based on the definition of a device in the Federal Food, Drug, and Cosmetic Act (FD&C Act). It also describes the criteria

Robbie Jost
Robbie Rogart Jost is a counsel in the Mass Tort, Product, and Consumer Litigation, Product Risk Management, and Litigation groups in Crowell & Moring's Washington, D.C. office. Robbie represents clients across numerous industries in a diverse array of commercial, class action, multi-district, health care, and products liability litigations in state and federal courts. Robbie also provides counseling regarding product liability, risk management, and consumer product regulatory compliance, with a focus on health care and medical devices.
Contact:Read more about Robbie Jost